Cipla Ltd.

₹1314.85

- 56.70 (-4.13%)

04:01 pm - close price

BSE: CIPLA

NSE: CIPLA

Industry: Pharmaceuticals & Drugs

House: Cipla

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: 65.29Good: 5

✅

Adjusted EPS

Bad: 3Current: 65.29Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 23.64Good: 20

✅

Current Ratio

Bad: 1Current: 4.24Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 18.34Good: 15

✅

Debt to Total Assets

Bad: 1Current: 0.25Good: 0.5

✅

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 65.29Good: 5

✅

Adjusted EPS

Bad: 3Current: 65.29Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 23.64Good: 20

✅

Current Ratio

Bad: 1Current: 4.24Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 18.34Good: 15

✅

Debt to Total Assets

Bad: 1Current: 0.25Good: 0.5

✅

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	6328.89	6678.15	6603.81	6163.24	6693.94
Expenditure+	4834.98	4944.40	4856.28	4847.38	4978.14
Other Income+	136.29	176.32	184.63	249.33	160.19
Operating Profit	1493.91	1733.75	1747.53	1315.86	1715.80
Interest	16.39	25.80	30.10	17.59	17.95
Depreciation and Amortization	239.21	290.04	233.43	288.34	246.68
Profit Before Tax	1376.09	1593.78	1473.71	1256.73	1610.53
Tax+	378.02	438.41	405.30	324.86	435.07
Net Profit	998.07	1155.37	1068.41	931.87	1175.46

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	19159.59	21763.34	22753.12	25774.09	27547.62
Operational Expenses+	14910.94	17251.38	17762.83	19483.04	20419.72
Operating Profit	4248.65	4511.96	4990.29	6291.05	7127.90
Other Income	269.77	321.73	512.13	746.57	861.87
OPM %	22.18	20.73	21.93	24.41	25.87
Depreciation and Amortisation	1067.66	1051.95	1172.11	1051.02	1106.95
Interest	160.70	106.35	109.54	89.88	62.01
Profit Before Tax	3290.06	3493.27	4038.35	5701.90	6820.81
Tax	871.20	921.70	1189.15	1539.11	1682.52
Net Profit	2404.87	2516.75	2801.91	4121.55	5272.52

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	24837.20	26652.29	29006.74	32130.02	36742.17
Liabilities+	24837.20	26652.29	28930.34	32130.02	36742.17

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	3755.20	3325.90	3237.65	4133.91	5004.98
Cash from Investing Activity	-2387.18	-1871.88	-2388.51	-2988.03	-3691.14
Cash from Financing Activity	-1239.51	-1599.79	-958.29	-1200.43	-1292.79
Net Cash Flow	128.51	-145.77	-109.15	-54.55	21.05
Opening Cash & Cash Equivalents	649.13	790.43	658.11	561.33	512.34
Closing Cash & Cash Equivalents	790.43	658.11	561.33	512.34	542.65

Shareholder Pattern

In %	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23
Promoters+	29.21	29.21	29.19	29.20	29.19	30.92	30.91	33.47	33.47	33.47
Public+	70.79	70.79	70.81	70.80	70.81	69.08	69.09	66.53	66.53	66.53
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	540521	534587	549655	543420	525114	470234	463569	436154	425731	426863

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	19159.59	21763.34	22753.12	25774.09	27547.62
Operational Expenses+	14910.94	17251.38	17762.83	19483.04	20419.72
Operating Profit	4248.65	4511.96	4990.29	6291.05	7127.90
Other Income	269.77	321.73	512.13	746.57	861.87
OPM %	22.18	20.73	21.93	24.41	25.87
Depreciation and Amortisation	1067.66	1051.95	1172.11	1051.02	1106.95
Interest	160.70	106.35	109.54	89.88	62.01
Profit Before Tax	3290.06	3493.27	4038.35	5701.90	6820.81
Tax	871.20	921.70	1189.15	1539.11	1682.52
Net Profit	2404.87	2516.75	2801.91	4121.55	5272.52

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	3755.20	3325.90	3237.65	4133.91	5004.98
Cash from Investing Activity	-2387.18	-1871.88	-2388.51	-2988.03	-3691.14
Cash from Financing Activity	-1239.51	-1599.79	-958.29	-1200.43	-1292.79
Net Cash Flow	128.51	-145.77	-109.15	-54.55	21.05
Opening Cash & Cash Equivalents	649.13	790.43	658.11	561.33	512.34
Closing Cash & Cash Equivalents	790.43	658.11	561.33	512.34	542.65

Ratios

Reported EPS

Bad: 2Current: 65.29Good: 5

✅

Adjusted EPS

Bad: 3Current: 65.29Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 23.64Good: 20

✅

Current Ratio

Bad: 1Current: 4.24Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 18.34Good: 15

✅

Debt to Total Assets

Bad: 1Current: 0.25Good: 0.5

✅

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 65.29Good: 5

✅

Adjusted EPS

Bad: 3Current: 65.29Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 23.64Good: 20

✅

Current Ratio

Bad: 1Current: 4.24Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 18.34Good: 15

✅

Debt to Total Assets

Bad: 1Current: 0.25Good: 0.5

✅

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	24837.20	26652.29	29006.74	32130.02	36742.17
Liabilities+	24837.20	26652.29	28930.34	32130.02	36742.17

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Shareholder Pattern

In %	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23
Promoters+	29.21	29.21	29.19	29.20	29.19	30.92	30.91	33.47	33.47	33.47
Public+	70.79	70.79	70.81	70.80	70.81	69.08	69.09	66.53	66.53	66.53
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	540521	534587	549655	543420	525114	470234	463569	436154	425731	426863

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	6328.89	6678.15	6603.81	6163.24	6693.94
Expenditure+	4834.98	4944.40	4856.28	4847.38	4978.14
Other Income+	136.29	176.32	184.63	249.33	160.19
Operating Profit	1493.91	1733.75	1747.53	1315.86	1715.80
Interest	16.39	25.80	30.10	17.59	17.95
Depreciation and Amortization	239.21	290.04	233.43	288.34	246.68
Profit Before Tax	1376.09	1593.78	1473.71	1256.73	1610.53
Tax+	378.02	438.41	405.30	324.86	435.07
Net Profit	998.07	1155.37	1068.41	931.87	1175.46

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Cipla Ltd.

₹1314.85

- 56.70 (-4.13%)

04:01 pm - close price

BSE: CIPLA

NSE: CIPLA

Industry: Pharmaceuticals & Drugs

House: Cipla

Overview